The leading domestic pharmaceutical manufacturers were included in the list. NANOLEK ranked 19th. The long-listed companies match the industrial parameter “Production of medicinal products and materials for humans use”.

The assessment used the weights method and was based on five criteria: revenue for 2019; changes in annual revenue; net profit; number of medicinal products for which marketing authorizations were issued per company and the number of clinical study permits issued in favor of the company.

Financial performance was collected from public sources in the SPARK system; information on marketing authorization issue and clinical study permits - from the State Register of Medicinal Products (data as of August 5, 2020).

We congratulate employees of NANOLEK, colleagues and partners!

We wish you conquering new peaks!